Axsome Therapeutics AXSM Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeNet.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's interest income?
- Axsome Therapeutics (AXSM) reported interest income of -$1.19M in Q1 2026.
- How has Axsome Therapeutics's interest income changed year-over-year?
- Axsome Therapeutics's interest income increased by 51.3% year-over-year, from -$2.43M to -$1.19M.
- What is the long-term trend for Axsome Therapeutics's interest income?
- Over 4 years (2021 to 2025), Axsome Therapeutics's interest income has grown at a 3.6% compound annual growth rate (CAGR), from -$5.7M to -$6.56M.
- What does interest income mean?
- Income earned from cash holdings and investments.
- How do you interpret interest income?
- Higher interest income indicates a larger cash balance or a more favorable interest rate environment.
- How does interest income compare across companies?
- Depends on the company's cash position and prevailing market interest rates.